AXIM BIOTECHNOLOGIES, INC. Increase (Decrease) in Accounts Receivable
AXIM BIOTECHNOLOGIES, INC. (AXIM) reported Increase (Decrease) in Accounts Receivable of $0 for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2022-11-15
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2021-09-30 was $11.10K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2021-06-30 was -$44.74K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2021-03-31 was $32.87K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2019 was $315.84K.
- AXIM BIOTECHNOLOGIES, INC. increase (decrease) in accounts receivable for fiscal 2018 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | $0.00 10-Q · filed 2022-08-16 | |||||
| 2021-09-30 | $11.10K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | -$33.64K derived: sum of 2 quarters · filed 2022-11-15 | -$770.00 10-Q/A · filed 2022-11-15 | |||
| 2021-06-30 | -$44.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-16 | -$11.87K 10-Q · filed 2022-08-16 | $11.87K 10-Q · filed 2021-08-23 | |||
| 2021-03-31 | $32.87K 10-Q · filed 2022-05-23 | |||||
| 2020-03-31 | $0.00 10-Q/A · filed 2021-06-02 | -$315.67K 10-Q/A · filed 2020-07-02 | $277.10K derived: sum of 2 quarters · filed 2021-06-02 | |||
| 2019-12-31 | $277.10K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $315.84K 10-K/A · filed 2020-05-20 | ||||
| 2019-09-30 | $38.75K 10-Q · filed 2019-11-14 | |||||
| 2019-03-31 | $13.00K 10-Q/A · filed 2020-07-02 | $13.00K derived: sum of 2 quarters · filed 2020-07-02 | ||||
| 2018-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-05-20 | $0.00 10-K/A · filed 2020-05-20 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-14 | |||||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-15 |